<doc>
  <docmeta id="113hr1239ih">
    <bill congress="113" type="hr" number="1239" version="ih"/>
    <revision size="5249" annotations="0" id="5" commit-time="2013-04-05T16:28:47+00:00" committer="favila" doc="113hr1239ih/5.xml" status="complete">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HE60B26F9DEFC4F92AD8BED1955E7EB53" public-private="public">
	<metadata>
<dublinCore>
<title>113 HR 1239 IH: Accessing Medicare Therapies Act of 2013</title>
<publisher>U.S. House of Representatives</publisher>
<date>2013-03-18</date>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 1239</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130318">March 18, 2013</action-date>
			<action-desc>
        <sponsor name-id="C001075">Mr. Cassidy</sponsor> (for
			 himself and <cosponsor name-id="M001163">Ms. Matsui</cosponsor>) introduced the
			 following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in
			 addition to the Committee on <committee-name committee-id="HWM00">Ways and
			 Means</committee-name>, for a period to be subsequently determined by the
			 Speaker, in each case for consideration of such provisions as fall within the
			 jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend part D of title XVIII of the Social Security Act
		  to count the negotiated price of drugs provided free or at nominal charge under
		  compassionate treatment programs towards incurred out-of-pocket
		  costs.</official-title>
	</form>
	<legis-body id="H3C753FA01F96417BB265AB6AD16D0305" style="OLC">
		<section id="H2A5FD40EB37744E881F4E1B1F1BBA130" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Accessing Medicare Therapies Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="H2FDD66953C924C298E779F2E04F7AE29" section-type="subsequent-section">
      <enum>2.</enum>
      <header>Counting the
			 negotiated price of drugs provided free or at nominal charge under
			 compassionate treatment programs towards incurred out-of-pocket costs</header>
			<subsection id="H7B8F97E140294B6EA9B2F8ED53C11475">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4">Section 1860D–2(b)(4)
			 of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">
              <cato:entity-ref entity-type="uscode" value="usc/42/1395w–102/b/4">42 U.S.C. 1395w–102(b)(4)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph id="HD2950193D1A446F38FE8E796994D00AB">
          <enum>(1)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:C">subparagraph
			 (C)</cato:entity-ref>, by striking <quote>
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:E">subparagraph (E)</cato:entity-ref>
            </quote> and inserting
			 <quote>
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:E">subparagraphs (E)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:F">(F)</cato:entity-ref>
            </quote>; and</text>
				</paragraph>
        <paragraph id="H8D3CCC99283B4B4CBE807056760DE86E">
          <enum>(2)</enum>
          <text>by adding at the
			 end the following new subparagraph:</text>
					<quoted-block display-inline="no-display-inline" id="H87274D01811E4066A5D232162F2CEF47" style="OLC">
						<subparagraph id="H0033FE0581294B1EA6EC53D95763303B">
              <enum>(F)</enum>
              <header>Inclusion of
				negotiated price of drugs provided under compassionate treatment
				programs</header>
							<clause id="H518C83F6BC7D4CFB84C1D5C7183DD765">
                <enum>(i)</enum>
                <header>In
				general</header>
                <text>In applying <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:A">subparagraph (A)</cato:entity-ref> with respect to an
				individual enrolled in a prescription drug plan, incurred costs shall include
				the negotiated price described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:F/cl:ii" proposed="true">clause (ii)</cato:entity-ref> of a covered part D drug
				if—</text>
								<subclause id="H3AB2A13935A841B1994D8312FD675338">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">the drug is classified, for purposes of
				applying tiered copayments consistent with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:2/sp:B">section 1860D–2(b)(2)(B)</cato:entity-ref>, in the
				highest copayment tier (such as a tier 4 for specialty brand-name drugs);</text>
								</subclause>
                <subclause id="H5075AEC42F07453BBCB60308B0CB283D">
                  <enum>(II)</enum>
                  <text>the drug is
				furnished to the individual free or at nominal charge under a compassionate
				treatment program (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–2/ss:b/p:4/sp:F/cl:iii" proposed="true">clause (iii)</cato:entity-ref>); and</text>
								</subclause>
                <subclause id="HB8F2BE75556246A8B309280FD3FDD9AB">
                  <enum>(III)</enum>
                  <text>the drug, if
				furnished other than through such program, is covered under the formulary of
				the plan or is available through exception or appeal.</text>
								</subclause>
              </clause>
              <clause id="H3927657E982345C99284A0F8698CAD48">
                <enum>(ii)</enum>
                <header>Negotiated
				price</header>
                <text>The negotiated price described in this clause, for a
				covered part D drug which is dispensed to an enrollee—</text>
								<subclause id="H510A1E3C04254F5497C6E688A84B40FE">
                  <enum>(I)</enum>
                  <text>by a pharmacy, is
				the negotiated price at such pharmacy; or</text>
								</subclause>
                <subclause id="HCC910514C08C45D396FA45F162EB61C3">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">other than by a pharmacy, is the average
				negotiated price for the drug in the prescription drug plan in the zip code of
				the enrollee as of the date the drug is dispensed.</text>
								</subclause>
              </clause>
              <clause id="H7204D1A3FCD2487EAC5EB02D40014A5F">
                <enum>(iii)</enum>
                <header>Compassionate
				treatment program defined</header>
                <text>In this subparagraph, the term
				<term>compassionate treatment program</term> means, with respect to covered
				part D drugs, a program that—</text>
								<subclause id="H36C0F255CE394BE4B5C839F936F124B8">
                  <enum>(I)</enum>
                  <text>is administered by
				an entity described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:501/ss:c/p:3">
                      <external-xref legal-doc="usc" parsable-cite="usc/26/501">section 501(c)(3)</external-xref> of the Internal Revenue Code of 1986</cato:entity-ref>
				that is exempt from tax under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:501/ss:a">section 501(a) of such Code</cato:entity-ref>;</text>
								</subclause>
                <subclause id="H951D15C7AD584B56B747C8771AA8EC90">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">takes title to the drugs and distributes
				the drugs to eligible part D individuals free or at nominal charge on the basis
				of the entity’s assessment of financial need of such individuals;</text>
								</subclause>
                <subclause id="H5FFEE87C08494F8C9FDCF7A271EE8D59">
                  <enum>(III)</enum>
                  <text>does not
				distribute the drugs to an individual unless the individual’s household income
				(as determined under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:36B">
                      <external-xref legal-doc="usc" parsable-cite="usc/26/36B">section 36B</external-xref> of the Internal Revenue Code of 1986</cato:entity-ref>) is less
				than the maximum income level for the taxpayer in the household to be eligible
				for a refundable credit under such section; and</text>
								</subclause>
                <subclause id="HA4961FB079DF48968388B88367297239">
                  <enum>(IV)</enum>
                  <text display-inline="yes-display-inline">meets such additional requirements as the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7504">Inspector General of the Department of Health and Human Services</cato:entity-ref> establishes,
				consistent with guidance and advisory opinions issued under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:1128D">section 1128D</cato:entity-ref>, to
				prevent fraud or abuse in the application of this
				subparagraph.</text>
								</subclause>
              </clause>
            </subparagraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection id="HC1BFC233868644E3AAC16774C88E3CEA">
        <enum>(b)</enum>
        <header>Effective
			 date</header>
        <text>The amendments made by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Accessing Medicare Therapies Act of 2013/s:2/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall apply to drugs
			 furnished in plan years beginning on or after January 1, 2014.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>